Specialty Pharma Journal Specialty, Precision & Technology
FRIENDSWOOD, Texas–(BUSINESS WIRE)–Castle Biosciences, Inc., the skin cancer diagnostics company providing molecular diagnostics to improve cancer treatment decisions, today announced the presentation of new data showing that the DecisionDx®-Melanoma test improved risk prediction beyond that using American Joint Committee on Cancer (AJCC) based staging. The study was presented at the …
Tag Archives: AJCC
August, 2018
January, 2016
-
20 January
New Precision Medicine Guidelines Aimed at Improving Personalized Cancer Treatment Plans
Tuesday, Jan 19th, 2016, Cleveland: A committee of national experts, led by a Cleveland Clinic researcher, has established first-of-its-kind guidelines to promote more accurate and individualized cancer predictions, guiding more precise treatment and leading to improved patient survival rates and outcomes. These new guidelines are changing the traditional approach of …